The Milner Therapeutics Consortium is excited announce its second call for research proposals, which is now open! The deadline for applications is 30th March 2022.
Our pharma partners in the Milner Therapeutics Consortium are working together with academics at the University, Babraham and Wellcome Sanger Institutes to better understand disease mechanisms and to discover and validate new therapeutic targets. These pre-clinical projects range from reagent sharing and 6-month pilots, to 2-year postdoctoral funded collaborations and are expected to lead to joint publications with the company partners.
Key neuroscience themes include:
Proposals from teams who are working across disciplines to apply new approaches to disease biology are particularly welcome. To learn more and download an application form, please see the Consortium Call website. Alternatively, you can email Nicola McCarthy, our Consortium Manager, at firstname.lastname@example.org
Posted on 14/02/2022